Skip to content

Analysis of Sublingual Glycocalyx Damage at ICU Admission to Predict Risk of Death

Analysis of Sublingual Glycocalyx Damage at ICU Admission to Predict Risk of Death - the ASGARD Study

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT03847493
Acronym
ASGARD
Enrollment
100
Registered
2019-02-20
Start date
2019-04-15
Completion date
2023-12-31
Last updated
2022-11-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Endothelial Dysfunction, Sepsis, Septic Shock

Keywords

perfused boundary region, PBR, Sepsis, endothelial glycocalyx, ICU

Brief summary

The aim of this observative, prospective study is to evaluate if and to what extent glycocalyx damage/microcirculation data at admission in the ICU as well as during ICU stay can be predictive of mortality and clinical course in patients presenting with the suspicion of sepsis/septic shock. Therefore, the enrollment of ca 100 ICU patients is planned.

Interventions

OTHEREndothelial Glycocalyx

Non-invasive assessment of endothelial glycocalyx dimensions.

Sponsors

University Hospital Muenster
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* ICU patients admitted to the ICU with the clinican suspicion of sepsis/septic shock.

Exclusion criteria

* Underage persons, pregnant women, patients with inflammation or trauma of sublingual mucosa.

Design outcomes

Primary

MeasureTime frameDescription
Predictive value of glycocalyx thickness regarding clinical course.Hospital stay, an expected time of 4 weeks.Glycocalyx thickness measured with the use of GlycoCheck System (Perfused Boundary Region - PBR, in µm). Clinical course will be estimated with the use of e.g. Sequential Organ Failure Assessment (SOFA) score (in points).
Predictive value of glycocalyx thickness regarding mortality.Hospital stay, an expected time of 4 weeks.Glycocalyx thickness measured with the use of GlycoCheck System (Perfused Boundary Region - PBR, in µm).

Secondary

MeasureTime frameDescription
Correlation of glycocalyx thickness with disease severity.Hospital stay, an expected time of 4 weeks.Glycocalyx thickness will be measured with the use of GlycoCheck System (Perfused Boundary Region - PBR, in μm). Disease severity will be assessed with ICU scores (e.g. SOFA Score - pts)

Countries

Germany

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 2, 2026